Skip to content

Levels Diagnostics Belgium: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Levels Diagnostics Belgium

BE 0797.796.690
NACE 72.101, Research and development on biotechnology
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€1,613
2024 · -€2,754+€1,141
Equity
-€4,167
2024 · -€2,554-€1,613
Cash
€36
2024 · €200-€164
Balance sheet total
€715
2024 · €575+€140

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€304

    up €304 (+81.2%), from €375 to €679

  • Cash -€164

    down €164 (-82.0%), from €200 to €36

    mainly Trade debts (-€2,339) and Net result for the year (-€1,613)

Equity and liabilities
  • Other debts +€4,093

    new in 2025: €4,093

  • Trade debts -€2,339

    down €2,339 (-74.8%), from €3,128 to €789

  • Profit (loss) carried forward -€1,613

    down €1,613 (-58.6%), from -€2,754 to -€4,367

Income statement
  • Gross operating margin +€1,049

    up €1,049 (+42.0%), from -€2,498 to -€1,449

  • Other operating charges -€256

    down €256 (-100%), from €256 to €0

  • Financial charges +€164

    new in 2025: €164

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€2,754
Gross operating margin +€1,049
Other operating charges +€256
Financial charges -€164
Result 2025 -€1,613
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€164
Investment €0
Financing €0
Cash 2024 €200
Net result for the year -€1,613
Receivables within one year -€304
Trade debts -€2,339
Other debts +€4,093
Cash 2025 €36
brings cash intakes cash out
Every line side by side 22 lines
Line Code 2024 2025 Change %
Total assets 20/58 €575 €715 +€140 +24.4%
Current assets 29/58 €575 €715 +€140 +24.4%
Amounts receivable within one year 40/41 €375 €679 +€304 +81.2%
Other amounts receivable 41 €375 €679 +€304 +81.2%
Cash at bank and in hand 54/58 €200 €36 -€164 -82.0%
Total equity and liabilities 10/49 €575 €715 +€140 +24.4%
Equity 10/15 -€2,554 -€4,167 -€1,613 -63.2%
Contributions 10/11 €200 €200 = 0.0%
Profit (loss) carried forward 14 -€2,754 -€4,367 -€1,613 -58.6%
Amounts payable 17/49 €3,128 €4,882 +€1,753 +56.0%
Amounts payable within one year 42/48 €3,128 €4,882 +€1,753 +56.0%
Trade debts 44 €3,128 €789 -€2,339 -74.8%
Suppliers 440/4 €3,128 €789 -€2,339 -74.8%
Other amounts payable 47/48 - €4,093 +€4,093
Other operating charges 640/8 €256 €0 -€256 -100%
Gross operating margin 9900 -€2,498 -€1,449 +€1,049 +42.0%
Operating profit (loss) 9901 -€2,754 -€1,449 +€1,305 +47.4%
Financial charges 65/66B - €164 +€164
Recurring financial charges 65 - €164 +€164
Profit (loss) for the period before taxes 9903 -€2,754 -€1,613 +€1,141 +41.4%
Profit (loss) for the period 9904 -€2,754 -€1,613 +€1,141 +41.4%
Profit (loss) for the period to be appropriated 9905 -€2,754 -€1,613 +€1,141 +41.4%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.